Who needs a mammogram or chest wall exam and how often?
Screening Guidelines for Lesbian & Bisexual Cisgender Women
- Ages 30 to 44 with family history of breast cancer or BMI greater than 35: consider starting regular mammograms early. Calculate your BMI here.
- Ages 40 to 44: Can elect to begin mammograms every 1-2 years.
- Ages 45 to 54: Annual mammogram recommended.
- Ages 55+:Mammogram recommended every 1-2 years.
Screening Guidelines for Trans Women
- Ages 50+ and older who have used HRT for more than 5 years: mammogram recommended every 2 years.
Screening Guidelines for Trans Men and Non-Binary Folks with Breast Tissue
No history of top surgery: Screening = Mammogram
History of breast reduction surgery only: Screening = Mammogram
History of top surgery: Screening = Chest wall and axillary exam
Ages 30 to 44 with family history of breast cancer or BMI greater than 35: consider starting regular breast/chest screening early. Calculate your BMI here.
- Age 40 to 44: Can elect to begin annual or biannual breast/chest screenings.
- Age 45 to 54: Annual breast/chest screenings recommended.
- Age 55+: Breast/chest screenings recommended every 1-2 years.
Mammogram and Chest Wall Guidelines
What is a mammogram?
A mammogram is a screening test for breast cancer. Typically, a mammogram involves two X-rays of each breast using a mammography machine. These X-rays can detect any irregularities or suspicious areas that may need further testing.
What is a chest wall/axillary exam?
A chest wall/axillary exam is the breast tissue and lymph node screening used for trans men and others who have had top surgery. Top surgery, unlike a complete double mastectomy, typically leaves breast tissue in the reconstructed chest. A chest wall and axillary exam usually begins with your primary care provider checking your chest and armpits for abnormalities. This exam can be part of your annual preventative care well-check. Based on family history of breast cancer and other factors, your provider may recommend an additional ultrasound or MRI in addition to the clinical screening.